BriaCell Therapeutics Corp.

UBS Group AG BCTX
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
11,541
Value ($000)
48
Weight
0.0%
2025 Q3 - 2026 Q1 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).